SEARCH
Quotes News NAV
Profit & Loss Markets  >  Corporate Information  >   Profit & Loss
Goldline Pharmaceutical Ltd Industry:  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code ISIN Demat Book Value
(R)
NSE
Symbol
Div Yield
%
Market Cap
(Rs.Cr)
P/E
(TTM)
EPS
(TTM)
Face Value
(R)
544759 INE1CLW01015 20.99625 Not Listed 0 44.29 0 0 10
     ParticularsMar 2025
(Rs.Cr)
Mar 2024
(Rs.Cr)
Mar 2023
(Rs.Cr)
INCOME :   
Sales Turnover 28.0623.5719.85
Excise Duty0.000.000.00
Net Sales28.0623.5719.85
Other Income 0.000.000.00
Stock Adjustments -0.712.12-0.09
Total Income27.3525.6919.76
EXPENDITURE :   
Raw Materials 10.098.195.74
Power & Fuel Cost0.020.020.02
Employee Cost 4.714.694.63
Other Manufacturing Expenses 0.040.010.02
Selling & Administrative Expenses 6.338.426.93
Miscellaneous Expenses 0.090.040.20
Less : Pre-operative Expenses Capitalised 0.000.000.00
Total Expenditure21.2921.3817.55
Operating Profit6.064.302.21
Interest 1.951.611.63
Gross Profit4.112.690.58
Depreciation0.250.160.18
Profit Before Tax3.862.530.40
Tax0.990.670.14
Fringe Benefit tax0.000.000.00
Deferred Tax0.030.050.01
Reported Net Profit2.831.810.26
Extraordinary Items -0.07-0.03-0.13
Adjusted Net Profit2.901.840.39
Adjustment below Net Profit -4.95-0.28-0.65
P & L Balance brought forward3.762.082.48
Statutory Appropriations0.000.000.00
Appropriations 0.00-0.150.00
P & L Balance carried down1.653.762.08
Dividend0.000.000.00
Preference Dividend0.000.000.00
Equity Dividend %0.000.000.00
Dividend Per Share(Rs)0.000.000.00
Earnings Per Share-Unit Curr4.117.851.28
Earnings Per Share(Adj)-Unit Curr4.117.851.28
Book Value-Unit Curr12.3926.3420.42
Book Value(Adj)-Unit Curr12.3926.3420.42